The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGILE THERAPEUTICS INC | COM | 00847L100 | 9,021 | 3,510,189 | SH | DFND | 3,510,189 | 0 | 0 | ||
CARLYLE GROUP L P | COM UTS LTD PTN | 14309L102 | 256 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
CHINACACHE INTL HLDG LTD | SPONSORED ADR | 16950M107 | 1,264 | 1,181,507 | SH | DFND | 1,181,507 | 0 | 0 | ||
MATTERSIGHT CORP | COM | 577097108 | 5,961 | 2,838,557 | SH | SOLE | 2,838,557 | 0 | 0 | ||
NASDAQ INC | COM | 631103108 | 1,672,163 | 19,394,142 | SH | SOLE | 19,394,142 | 0 | 0 | ||
SCHLUMBERGER LTD | COM | 806857108 | 648 | 10,000 | SH | SOLE | 10,000 | 0 | 0 |